BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2009
View Archived Issues
Results of first study of avian influenza vaccine in children
Read More
Chiome and Chugai sign joint research agreement for monoclonal antibodies
Read More
BioSeek and UCB establish new compound evaluation collaboration
Read More
Liquidia and Abbott sign collaboration and license agreement for siRNA therapeutics
Read More
GSK divulges a series of ghrelin receptor ligands for the treatment of binge eating
Read More
New GHS-R1a ligands claimed by GSK as a treatment option for obesity
Read More
New TLR modulators disclosed by Technische Universitaet Muenchen
Read More
GSK successfully completes tender offer for shares of Genelabs
Read More
CTI receives USD 7.5 million from Spectrum under U.S. joint venture agreement for Zevalin
Read More
OncoMed imparts novel anti-Jagged 1 monoclonal antibodies with anticancer properties
Read More
Novel mGluR2 metabotropic glutamate receptor agonists disclosed by AstraZeneca
Read More
Studies show GRII receptor antagonists prevent olanzapine-induced weight gain
Read More
First phase III Contrave trial meets co-primary and key secondary endpoints
Read More
Poniard presents 2009 clinical goals for development of chemotherapy drug picoplatin
Read More
FDA advisory committee recommends approval of Ovation's Sabril for IS and CPS
Read More
FDA approves Collegium's nasal inhaled steroid AllerNaze for SAR and PAR
Read More
Johnson & Johnson initiates phase I study of risperidone for schizophrenia
Read More
FDA issues second complete response letter regarding Merck & Co.'s sBLA for Gardasil
Read More
FDA approves Anesiva's sNDA to expand the indication for Zingo to include adults
Read More
Altus reports results from completed phase Ic study of ALTU-238
Read More
Galapagos and Merck & Co. enter global strategic alliance in obesity and diabetes
Read More
ThromboGenics initiates phase III MIVI-TRUST clinical program for microplasmin
Read More
Triiodothyronine promotes remyelination in a mouse model of multiple sclerosis
Read More
CDDO-imidazolide reduces lung damage in model of chronic obstructive pulmonary disease
Read More
Studies compare beta-blockers in adults and elderly patients with heart failure
Read More
